The IGF-1R pathway plays a major role in mediating the activation of prosurvival pathways and contributes to resistance to various anticancer therapies, including chemotherapies, radiation therapy, and molecular targeted therapies, in multiple cancer types [5–7, 11, 32]. This evidence concerns the gene IGF1R and cancer.